Research Alliance Corp III entered a material agreement; sold unregistered shares; made a public disclosure
SEC 8-KRead source ↗
Research Alliance Corp III is a US-listed company in the biotechnology industry. Its financial year ends in December.
Who’s trading
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
- Funds22 adding, 0 cuttingOf 10 active managers that changed their stake, 10 added; quarter to June 30, 2026Fund buyers and sellers
The Fundamentalytics view
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Price chart
- 1 day+0.2%
- 1 week0.0%
- 1 month-5.6%
Loading chart…
Third-party market data · may be delayed
At a glance
News & updates
Company announcements, filed results and changes that matter to shareholders.
- Agreement
No model value for Research Alliance Corp III at the moment. Current status: limited reported history: available models are shown without a Buy/Hold/Sell rating. Available reported financials are shown below.
Valuation models
We value Research Alliance Corp III as an operating company, with every model that fits that kind of business. Cost of equity 9.9%: the 10-year Treasury yield (4.9%) plus a beta of 1.1 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | — | No model applies: the filings don’t yet support a value. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Research Alliance Corp III with Biotechnology in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Forecasts and guidance
Analysts' consensus
No analyst estimates are published for Research Alliance Corp III: too few analysts cover it.
Positioning
- Short interest
- 0.1% of tradable shares
- Days to cover
- 0.21 at average volume
- Short interest, 1 month
- +57% to October 15, 2026
- Held by institutions
- — of shares
- Held by insiders
- 4.6% of shares
Share-price performance
Market data may be delayedPrice behaviour
- 52-week range
- Not enough history
- From 52-week high
- —
- vs 50-day average
- −18.2%
- vs 200-day average
- —
- Volatility (1 year)
- —
- Beta vs S&P 500
- —
Fundamentals
Who owns it
Funds buying and selling- Reported value
- $79.6M
- Institutions reporting
- 23
- Positions opened / closed
- 22 / 0
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Perceptive Advisors LLC | $8M | 750K | 10.1% | — |
| ADAR1 Capital Management, LLC | $7M | 650K | 8.7% | — |
| Trails Edge Capital Partners, LP | $5.3M | 500K | 6.7% | — |
| Commodore Capital LP | $5.3M | 500K | 6.7% | — |
| Bvf Inc | $5.3M | 500K | 6.7% | — |
| Balyasny Asset Management L.P. | $5.3M | 500K | 6.7% | — |
| Tcg Crossover Management, LLC | $5.3M | 500K | 6.7% | — |
| Spruce Street Capital LP | $5.3M | 500K | 6.7% | — |
| Jupiter Topco LLC | $4.4M | 400K | 5.5% | — |
| Braidwell LP | $4.3M | 400K | 5.4% | — |
| Cormorant Asset Management, LP | $4M | 370K | 5.0% | — |
| Affinity Asset Advisors, LLC | $4M | 370K | 5.0% | — |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Research Alliance Corp III's complete shareholder register. Values are as reported by the filers .
Insider trading activity
Full insider history and chart Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Results announcements
Recent SEC filings
- S-4 S-4
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- S-1 S-1
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Research Alliance Corp III in brief
- What does Research Alliance Corp III do?
- Research Alliance Corp III is a US-listed company in the biotechnology industry. Its financial year ends in December.
- What is Research Alliance Corp III's stock ticker?
- Research Alliance Corp III trades under the ticker RACC on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
- Who are Research Alliance Corp III's largest institutional shareholders?
- By value reported in 13F filings for June 30, 2026, the largest reported holders are Perceptive Advisors LLC, ADAR1 Capital Management, LLC and Trails Edge Capital Partners, LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Follow research on Research Alliance Corp III
New research on the companies we cover arrives in the weekly email. Free, one email a week.